Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 7Breast Neoplasms 5Ovarian Neoplasms 4Pancreatic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Triple Negative Breast Neoplasms 2Neoplastic Syndromes, Hereditary 2Hereditary Breast and Ovarian Cancer Syndrome 2Endometrial Neoplasms 2Colorectal Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Rectal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fanconi Anemia, Complementation Group D1 1Digestive System Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Risk Syndrome 1

Interventions

Cyclophosphamide 22Trastuzumab 16Paclitaxel 15Radiotherapy 13Docetaxel 13Capecitabine 11Doxorubicin 10Taxes 9Lapatinib 9Carboplatin 8Tamoxifen 7Immunohistochemistry 7Biopsy 7Albumin-Bound Paclitaxel 7Magnetic Resonance Spectroscopy 6Fluorodeoxyglucose F18 6Chemotherapy, Adjuvant 6Immunoenzyme Techniques 5Gemcitabine 5Flow Cytometry 5Bevacizumab 5sargramostim 4Vinorelbine 4Letrozole 4Irinotecan 4Granulocyte-Macrophage Colony-Stimulating Factor 4Filgrastim 4Everolimus 4Erlotinib Hydrochloride 4Cisplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms, Male × Genetic Counseling × Clear all
NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

University of Southern California

Phase NA Recruiting
800 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡